Regeneron
Regeneron CEO Leonard Schleifer ’73 Involved in Trump Experimental COVID-19 Treatment
|
Regeneron and CEO Leonard Schleifer ’73 have gained recognition for the experimental drug cocktail that has shown promising results in treating the initial symptoms of COVID-19 infections.